Company Filing History:
Years Active: 2017-2025
Title: Jeff Sands: Innovator in Nephrogenic Diabetes Insipidus Treatment
Introduction
Jeff Sands is a notable inventor based in Atlanta, GA (US), recognized for his contributions to the field of medical treatments, particularly in managing nephrogenic diabetes insipidus. With a total of 5 patents to his name, Sands has made significant strides in developing innovative solutions for this condition.
Latest Patents
Sands' latest patents focus on the use of substituted cycloalkanes for managing nephrogenic diabetes insipidus. One of his key inventions involves methods of treating or preventing this condition by administering effective amounts of compounds from the class of alkyl carboxylic acids, such as 1,1'-(decane-1,10-diyl)bis(cyclopropane-1-carboxylic acid), along with pharmaceutical salts or derivatives. Another patent emphasizes the use of 1,1′-(dodecane-1,12-diyl)bis(cyclopropane-1-carboxamide) for similar therapeutic purposes, targeting subjects diagnosed with nephrogenic diabetes insipidus.
Career Highlights
Throughout his career, Sands has worked with prominent organizations, including Nephrodi Therapeutics, Inc. and Emory University. His work in these institutions has allowed him to collaborate with other experts in the field, further enhancing his research and development efforts.
Collaborations
Some of Sands' notable coworkers include Janet Klein and Ish Khanna. Their collaborative efforts have contributed to the advancement of treatments for nephrogenic diabetes insipidus.
Conclusion
Jeff Sands stands out as an innovative inventor dedicated to improving the lives of those affected by nephrogenic diabetes insipidus. His patents and collaborations reflect his commitment to advancing medical science and providing effective solutions for patients in need.